Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia
Vagner O.C. Rigaud, Clare Zarka, Justin Kurian, Daria Harlamova, Andrea Elia, Nicole Kasatkin, Jaslyn Johnson, Michael Behanan, Lindsay Kraus, Hannah Pepper, Nathaniel W. Snyder, Sadia Mohsin, Steven R. Houser, Mohsin Khan
Vagner O.C. Rigaud, Clare Zarka, Justin Kurian, Daria Harlamova, Andrea Elia, Nicole Kasatkin, Jaslyn Johnson, Michael Behanan, Lindsay Kraus, Hannah Pepper, Nathaniel W. Snyder, Sadia Mohsin, Steven R. Houser, Mohsin Khan
View: Text | PDF
Research Article Cardiology Metabolism

UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia

  • Text
  • PDF
Abstract

Developmental cardiac tissue is regenerative while operating under low oxygen. After birth, ambient oxygen is associated with cardiomyocyte cell cycle exit and regeneration. Likewise, cardiac metabolism undergoes a shift with cardiac maturation. Whether there are common regulators of cardiomyocyte cell cycle linking metabolism to oxygen tension remains unknown. The objective of the study is to determine whether mitochondrial UCP2 is a metabolic oxygen sensor regulating cardiomyocyte cell cycle. Neonatal rat ventricular myocytes (NRVMs) under moderate hypoxia showed increased cell cycle activity and UCP2 expression. NRVMs exhibited a metabolic shift toward glycolysis, reducing citrate synthase, mtDNA, mitochondrial membrane potential (ΔΨm), and DNA damage/oxidative stress, while loss of UCP2 reversed this phenotype. Next, WT and mice from a global UCP2-KO mouse line (UCP2KO) kept under hypoxia for 4 weeks showed significant decline in cardiac function that was more pronounced in UCP2KO animals. Cardiomyocyte cell cycle activity was reduced, while fibrosis and DNA damage was significantly increased in UCP2KO animals compared with WT under hypoxia. Mechanistically, UCP2 increased acetyl-CoA levels and histone acetylation, and it altered chromatin modifiers linking metabolism to cardiomyocyte cell cycle under hypoxia. Here, we show a potentially novel role for mitochondrial UCP2 as an oxygen sensor regulating cardiomyocyte cell cycle activity, acetyl-CoA levels, and histone acetylation in response to moderate hypoxia.

Authors

Vagner O.C. Rigaud, Clare Zarka, Justin Kurian, Daria Harlamova, Andrea Elia, Nicole Kasatkin, Jaslyn Johnson, Michael Behanan, Lindsay Kraus, Hannah Pepper, Nathaniel W. Snyder, Sadia Mohsin, Steven R. Houser, Mohsin Khan

×

Figure 2

Hypoxia-induced UCP2 overexpression is associated with glycolytic metabolism and reduced oxidative damage in cardiomyocytes.

Options: View larger image (or click on image) Download as PowerPoint
Hypoxia-induced UCP2 overexpression is associated with glycolytic metabo...
(A and B) Measurement of oxygen consumption rate (OCR) (A) and extracellular acidification rates (ECAR) (B) by Seahorse Bioanalyzer show decreased mitochondrial respiration and increased glycolysis, respectively, in NRVMs after 48 hours under hypoxia compared with 48 hours under normoxic conditions (n = 12 replicates/condition/3 independent experiments). Data for OCR/ECAR was normalized to cell number. (C–E) Further validation shows increased mRNA levels of glycolytic enzymes (C), reduced citrate synthase activity (D), and reduced mitochondrial DNA content (E) in moderate hypoxic NRVMs compared with their normoxic counterparts. (n = 3/condition/experiment). (F) Hypoxic NRVMs demonstrate lower mitochondrial membrane potential visualized by TMRM staining. TMRM, red; nuclei, blue. (n = 3). Scale bar: 20 μm. (G) Reduced mitochondrial superoxidase production in NRVMs under hypoxia compared with NVRMs in normoxia measured by MitoSOX intensity. Scale bar: 20 μm (n = 3). (H and I) Reduced levels of the oxidative DNA damage marker 8-OHdG (H) and DNA double-strand breaks marker γH2A.X (I) in NRVMs under hypoxia. 8-OHdG/γH2A.X, green; cardiac troponin T, red; nuclei, blue. Scale bar: 40 μm. (n = 3). (J) Reduced mRNA expression of DNA damage markers ATM and ATR and increased antioxidant markers SOD1, GPX, and GR in NRVMs under hypoxia compared with normoxia (n = 4). *P < 0.05, **P < 0.01, ****P < 0.0001. Data from A–C and J were analyzed using Kruskal-Wallis test with Dunn’s correction for multiple comparisons; data for D–I were analyzed by Mann-Whitney U test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts